AR121189A2 - Anticuerpos anti-tigit y métodos de uso - Google Patents

Anticuerpos anti-tigit y métodos de uso

Info

Publication number
AR121189A2
AR121189A2 ARP210100111A ARP210100111A AR121189A2 AR 121189 A2 AR121189 A2 AR 121189A2 AR P210100111 A ARP210100111 A AR P210100111A AR P210100111 A ARP210100111 A AR P210100111A AR 121189 A2 AR121189 A2 AR 121189A2
Authority
AR
Argentina
Prior art keywords
methods
tigit antibodies
tigit
antibodies
domained
Prior art date
Application number
ARP210100111A
Other languages
English (en)
Inventor
Jane L Grogan
Robert J Johnston
Yan Wu
Wei Liang
- Lupardus Patrick Ching
Mahesh Yadav
Dhaya Seshasayee
Meredith Hazen
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of AR121189A2 publication Critical patent/AR121189A2/es

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

La presente se refiere a anticuerpos anti-TIGIT (inmunoreceptor de células T con dominios de Ig e ITIM) y métodos de uso de los mismos.
ARP210100111A 2015-09-25 2021-01-18 Anticuerpos anti-tigit y métodos de uso AR121189A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562233230P 2015-09-25 2015-09-25

Publications (1)

Publication Number Publication Date
AR121189A2 true AR121189A2 (es) 2022-04-27

Family

ID=60931770

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP160102929A AR106146A1 (es) 2015-09-25 2016-09-26 Anticuerpos anti-tigit y métodos de uso
ARP210100111A AR121189A2 (es) 2015-09-25 2021-01-18 Anticuerpos anti-tigit y métodos de uso

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP160102929A AR106146A1 (es) 2015-09-25 2016-09-26 Anticuerpos anti-tigit y métodos de uso

Country Status (1)

Country Link
AR (2) AR106146A1 (es)

Also Published As

Publication number Publication date
AR106146A1 (es) 2017-12-13

Similar Documents

Publication Publication Date Title
CL2018000595A1 (es) Anticuerpos anti-pd1 y métodos de uso
CL2019002824A1 (es) Anticuerpos anti-lag3.
ECSP18007905A (es) Anticuerpos monoclonales contra bcma
CO2017013351A2 (es) Moduladores cot y métodos de uso de los mismos
MX2022002959A (es) Anticuerpos anti-tigit y metodos de uso.
CR20150618A (es) Anticuerpos receptores de antitransferina y métodos de uso
CO2018000244A2 (es) Anticuerpos madurados por afinidad y humanizados para fcrh5
ECSP18000844A (es) Anticuerpos de unión a tau
CL2016002455A1 (es) Anticuerpos multiespecíficos.
CL2017001361A1 (es) Anticuerpos heterodiméricos que se unen a cd3 y cd38
BR112015032224A2 (pt) anticorpos anti-fcrh5
CR20160500A (es) Anticuerpos anti-ox40 y métodos de uso
CO2017006740A2 (es) Anticuerpos anti–cd79b
CL2018000479A1 (es) Linfoopeitina strimal tomica (tslp) - anticuerpos de union y metodos de uso de los anticuerpos
CL2020002540A1 (es) Anticuerpos anti-hla-g y utilización de los mismos
CU20170074A7 (es) Anticuerpos heterodiméricos que se unen a cd3 y a antígenos tumorales
BR112017011932A8 (pt) Anticorpos direcionados a receptor acoplado a proteína g e métodos de uso
BR112017023943A2 (pt) anticorpos heterodimêricos que ligam cd3 e antígenos de tumor
PE20181005A1 (es) Anticuerpos biespecificos contra el a- beta humano y el receptor de transferrina humano y metodos de uso
PE20210648A1 (es) Anticuerpos anti-cd3 y metodos de uso
EA201791029A1 (ru) Антитела против интерлейкина-33 и их применение
BR112017009297A2 (pt) anticorpos antifator de complemento c1q humanizados e usos dos mesmos
ECSP18000887A (es) Anticuerpos de unión a tau
CR20160270A (es) ANTICUERPOS ANTI-TAU (pS422) HUMANIZADOS Y MÉTODOS DE UTILIZACIÓN
CO2020012360A2 (es) Anticuerpos multiespecíficos y utilización de los mismos